AGP Executive Report
Last update: 7 hours agoReal-World ENT Breakthrough (Italy): A multicenter MEPOREAL phase 4 study in Italian tertiary rhinology clinics reports that mepolizumab improves severe, uncontrolled chronic rhinosinusitis with nasal polyps—cutting nasal polyp score and SNOT-22 and boosting smell, obstruction and rhinorrhea outcomes at 12 months, published in The Lancet Respiratory Medicine. Mental Health Digital Care: A new market report forecasts rapid growth for mental health apps, driven by reimbursement pathways for digital therapeutics and wider employer adoption. Pediatric Oncology Research (Italy): Recordati announces Dr. Laura Broutier as winner of the Arrigo Recordati Prize for Scientific Research, funding her DISARMS project targeting fusion-negative rhabdomyosarcoma in children. Food Systems Citizen Science (Italy): The SPOON project launches a third Citizen Science Lab round across six countries, including Italy (Turn), to help co-create digital tools for healthier, more sustainable everyday food routines. Health Tech & Pharma (EU/Italy): Lupin’s VISUfarma secures EU commercialization rights for Yuvezzi, a once-daily eye drop aimed at temporary near-vision support for part of the day. Wellness & Climate Context: Coverage highlights how prolonged heatwaves are stressing European housing and how thermal wellness experiences are expanding in hospitality.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
